Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The "reset button" revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients.
Verburg FA, Luster M, Giovanella L, Lassmann M, Chiesa C, Chouin N, Flux G; EANM Thyroid, Radiation Protection and Dosimetry Committees. Verburg FA, et al. Among authors: lassmann m. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):915-917. doi: 10.1007/s00259-017-3649-9. Epub 2017 Feb 16. Eur J Nucl Med Mol Imaging. 2017. PMID: 28210770 No abstract available.
Effect of specific activity on cardiac uptake of iodine-123-MIBG.
Farahati J, Bier D, Scheubeck M, Lassmann M, Schelper LF, Grelle I, Hanscheid H, Biko J, Graefe KH, Reiners C. Farahati J, et al. Among authors: lassmann m. J Nucl Med. 1997 Mar;38(3):447-51. J Nucl Med. 1997. PMID: 9074536 Free article.
Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma.
Luster M, Sherman SI, Skarulis MC, Reynolds JR, Lassmann M, Hänscheid H, Reiners C. Luster M, et al. Among authors: lassmann m. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1371-7. doi: 10.1007/s00259-003-1230-1. Epub 2003 Jul 15. Eur J Nucl Med Mol Imaging. 2003. PMID: 12856155 Clinical Trial.
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.
Pacini F, Ladenson PW, Schlumberger M, Driedger A, Luster M, Kloos RT, Sherman S, Haugen B, Corone C, Molinaro E, Elisei R, Ceccarelli C, Pinchera A, Wahl RL, Leboulleux S, Ricard M, Yoo J, Busaidy NL, Delpassand E, Hanscheid H, Felbinger R, Lassmann M, Reiners C. Pacini F, et al. Among authors: lassmann m. J Clin Endocrinol Metab. 2006 Mar;91(3):926-32. doi: 10.1210/jc.2005-1651. Epub 2005 Dec 29. J Clin Endocrinol Metab. 2006. PMID: 16384850 Clinical Trial.
206 results